Literature DB >> 2579035

The plasmin system in human colonic tumors: an immunofluorescence study.

P Burtin, G Chavanel, J Andre.   

Abstract

We studied the plasmin system with specific antisera to plasminogen, its 2 activators (urokinase-type and tissue-type) and the 2 plasmin inhibitors, alpha 2 anti-plasmin and alpha 2 macroglobulin on sections of 34 human colonic tumors by immunofluorescence. Anti-plasminogen serum showed a clear-cut reactivity at the surface of tumor cells, as it stained the contour of tumor glandular structures, foci, and isolated tumor cells. Intratumoral deposits and necrotic areas were stained as well, often strongly. Localization of plasminogen was quite different from that of fibrinogen, which was found only in peritumoral stroma, and never on tumor cells. Traces of both types of plasminogen activator were found, mainly on invasive tumor cells for urokinase type and on large tumor foci for tissue type. Images were weak and inconstant. Large amounts of both plasmin inhibitors were characterized in tumor stroma. Alpha-2 anti-plasmin was also found in intratumoral deposits and necrotic areas. It seems likely that plasminogen exudes from blood capillaries (since anti-plasminogen serum often stained the whole capillary wall), diffuses in the stroma and binds to tumor cells. Once formed, plasmin is likely to play a role in the invasion of surrounding tissues by tumor cells, in the dissociation of tumor cells from tumor glands and in the production of necrosis inside tumor areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579035     DOI: 10.1002/ijc.2910350305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

2.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

Authors:  K A Hajjar; R L Nachman
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.

Authors:  F Jänicke; M Schmitt; L Pache; K Ulm; N Harbeck; H Höfler; H Graeff
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Secretion of plasminogen activators by human colorectal and gastric tumor explants.

Authors:  S R Harvey; D D Lawrence; J M Madeja; S J Abbey; G Markus
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

5.  Plasminogen inhibits TNFalpha-induced apoptosis in monocytes.

Authors:  Jennifer W Mitchell; Nagyung Baik; Francis J Castellino; Lindsey A Miles
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

6.  Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin.

Authors:  Rachael J Borg; Andre L Samson; Amanda E-L Au; Anja Scholzen; Martina Fuchsberger; Ying Y Kong; Roxann Freeman; Nicole A Mifsud; Magdalena Plebanski; Robert L Medcalf
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Plasminogen receptors on rat colon carcinoma cells.

Authors:  M Durliat; O Komano; P Correc; O Bertrand; S Cochet; A Caignard; F Martin; P Burtin
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.